The genome of hepatitis A virus (HAV) was reverse transcribed into cDNA and molecularly cloned. cDNA clones coding for the capsid protein VP1 that carries the major HAV antigen were cloned into the expression vector pUR290 and expressed in Escherichia coli. The recombinant fusion protein reacted in an immunoblot with rabbit anti-HAV serum, suggesting that it possesses HAV antigenicity.
Hepatitis A virus (HAV) is a member of the picornaviruses and is classified as type 72 in the genus Enterovirus (12) . Propagation of HAV in various cell cultures (4, 6, 11, 15) yields only limited amounts of virus, and the pattern of replication is remarkably different from that of other picornaviruses. HAV grows in cell cultures without obvious cythopathic effects, and its replication is much slower than that of other picornaviruses; i.e., a significant titer increase generally cannot be detected before 1 to 2 weeks, and longer incubation periods are needed before reasonable amounts of viral antigen are obtained. These properties have hampered biochemical and, particularly, molecular studies to elucidate the antigenicity of HAV. Apart from the limited virus yields, another problem is that host cells must be disintegrated to recover the virus, and the virus must be purified from the cellular debris, making it difficult to produce pure viral antigens for diagnostic tests and vaccines. These problems led to the molecular cloning and biological amplification of the HAV genome in Escherichia coli (1, 10, 13, 18, 19) .
In a previous paper (19) , we reported incomplete cDNA cloning of the HAV genome; here we report cloning of the entire viral genome and expression of cDNA clones coding for the structural viral protein VP1 in E. coli, leading to a recombinant protein with HAV antigenicity (14) .
Cloning. The MBB isolate (4) of HAV was propagated in a human hepatocellular carcinoma cell line (PLCIPRF/5), and the virus was purified essentially as described previously (19 (RNA blot) hybridization to HAV RNA which had been extracted from highly purified virus and which had a size of 7.5 kilobases (32S), typical for HAV RNA (2, 17) . HAVspecific cDNA clones were nick translated and used as molecular probes for screening additional clones by the technique of Grunstein and Hogness (7). HAV-specific cDNA clones were aligned along the HAV genome, beginning at the 3' end of the RNA [identified by hybridization to poly(A)] and extending to the physical 5' end of the genome. The mapping was checked by hybridization of various clones to each other by Southern blot hybridization analysis.
Nine representative cDNA clones, overlapping each other and covering the entire genome, and a map of restriction enzyme sites of the genome which were deduced from these clones are shown in Fig. 1 .
Expression of VP1 cDNA clones in E. coli. Recent results from biochemical and immunological studies (3, 8, 9) indicate that, as in other picornaviruses, the capsid protein VP1 of HAV contains a major antigen. We reconstructed various HAV cDNA clones coding for part or all of VP1, inserted them into the expression vector pUR290 (16) (Fig. 2) , and studied the expression of HAV VP1. The HAV cDNA clones were inserted into the plasmid vector pUR290 so that the HAV sequences were fused just before the 3' end of the lacZ gene, thus yielding a fusion protein of the ,B-galactosidase and the joined HAV VP1 sequences.
E. coli cultures were transformed with each of the clones and grown to confluence, the promoter was induced by addition of isopropylthiogalactoside; and incubation was continued for 90 min. The bacteria were lysed and sonified, and the lysate was analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis, either stained with Coomassie blue (Fig. 3A) 3A] ); they were not detected in the nonihduced lysate. It is interesting that whereas the fusion proteins of clones 290-17 and 290-17-7, which contained the N-terminal third of the VP1 sequence, reacted with anti-HAV, the recombinant proteins of pUR290 and 290-5-2 did not, indicating that HAV antigenicity might be determined within the N-terminal amino acids of VP1 (NcoI to BamHI, about 60 amino acids [ Fig. 2]) .
The solubility of the antigenic recombinant protein was determined by pelleting the crude bacterial lysate and analyzing the pellet and the supernatant fraction separately by polyacrylamide gel electrophoresis (data not shown). About 10 to 20% of the antigenic protein in the lysate was soluble, but most of the antigenic protein was present in the pellet fraction, as seen with other recombinant proteins (16) . Attempts to analyze the antigenicity of the recombinant protein in an enzyme-linked immunosorbent assay were unsatisfactory because of the high degree of insoluble antigenic material that could not be coated to the plate.
Our recombinant proteins reacted with rabbit anti-HAV serum but not with human convalescent-phase serum; it is possible that convalescent-phase serum only recognizes intact virion structures, whereas our rabbit serum also recognizes disintegrated (i.e., VP1) cated at VP1 between amino acids 5 and 114. These data together with ours suggest that the HAV VP1 carrying the (or one of the) antigenic site(s) responsible for inducing neutralizing antibodies is closer to the N-terminal end of VP1 than in other picornaviruses.
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